Clinical Trial: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Study Type: INTERVENTIONAL
Official Title: Pilot Study of HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Brief Summary:
The objective of this clinical study is to compare the safety and effectiveness of Valchlor versus HyBryte following 12 weeks of treatment.
Read more